市場調查報告書
商品編碼
1168275
醫療保健的機器人工學市場- 各主題情報Robotics in Healthcare - Thematic Intelligence |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
醫療機構將加大對醫療機器人的投資,以填補人員短缺並提高護理標準。2020年醫療保健機器人市場價值47億美元。預計未來該市場將以12%的年複合成長率成長,到2030年將達到145億美元。在骨科和神經外科機器人銷量成長的推動下,手術機器人有望引領市場。
本報告提供醫療保健的機器人工學市場相關調查,市場概要,以及市場規模與成長預測,機器人工學對醫療保健的影響等。
Macroeconomic factors will drive healthcare's use of robotics
The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.
Medical robots improve the standard of care
Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.
Double-digit growth is expected in the next decade
Robotics is a fast-growing industry. GlobalData expects every segment of the robotics market to grow over the next decade. According to GlobalData forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.
Industrial robots will enhance smart pharma manufacturing
The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, GlobalData's Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.